National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

[18F]-labeled substance P antagonist receptor quantifier
A radioconjugate consisting of the positron emitting radioisotope fluorine F 18 conjugated to the substance P antagonist receptor quantifier (SPA-RQ) used in radioimaging. [18F]-labeled substance P antagonist receptor quantifier is an antagonist of the neurokinin 1 (substance P) receptor (NK1R) and can function as a positron emission tomography (PET) imaging agent for detecting NK1R-expressing cells and tissues. NK1Rs are frequently expressed on the plasma membranes of tumor cells from glioblastoma and breast and pancreatic carcinomas. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:[18F]SPA-RQ

Previous:7-hydroxystaurosporine, 8-hydroxyquinoline sulfate ointment, 851B gel, 852A, 99mTc-DTPA-mannosyl-dextran
Next:[18F]-ML-10, [F-18]HX4, abagovomab, abarelix, Abegrin